期刊文献+

曲古菌素A对去乙酰化酶2在子宫内膜癌细胞株HEC-1B中表达的影响 被引量:4

Effect of trichostatin A on the expression of HDAC2 in HEC-1B cells.
在线阅读 下载PDF
导出
摘要 目的研究曲古菌素A(TSA)对子宫内膜癌细胞株HEC-1B中去乙酰化酶2(HDAC2)和p53表达的影响,及TSA对HEC-1B增殖的抑制作用,探讨TSA诱导HEC-1B细胞增殖抑制的机制。方法用不同浓度的TSA(100、200、400nmol/L)分组培养HEC-1B细胞(0、24、48、72h),用四甲基偶氮唑蓝(MTT)法测定不同浓度、不同时间的TSA作用后子宫内膜癌HEC-1B细胞的增殖率。应用Western Blot以及RT-PCR方法检测HDAC2和p53的表达水平,研究TSA对其表达的影响。结果TSA对HEC-1B细胞的增殖具有明显的抑制作用,并呈时间依赖性(P<0.01)。HDAC2在该细胞中的表达随TSA的剂量和时间呈减弱趋势,而p53的表达呈升高趋势。结论TSA具有去乙酰化酶抑制剂作用,抑制HDAC2的表达并促进肿瘤抑制因子p53的活化与表达,能够抑制子宫内膜癌细胞的增殖。 Objective To investigate the depressant effect and mechanism of trichostatin A (TSA) on proliferation and being induced apoptosis of Histone deacetylase 2 (HDAC2) and p53 in human endometrial cancer-1B cell line (HEC-1B). Methods Three levels concentration of TSA ( 100, 200,400 nmol/L) on HEC-1B at different time duration (0, 24,48, 72 hours) were applied. The expression of HDAC2 in HEC-IB was examined using Western Blot and the data was analyzed with different concentrations of TSA at various treating time duration. The proliferation and apoptotic rates of HEC-1B and the effect of TSA on them were determined using MTT method. At the same testing condition, the expression level of HDAC and p53 in HEC-1B and the effect of TSA were determined using reverse transeription-polymerase chain reaction (RT-PCR). Results TSA has significant inhibition effect on proliferation of HEC-1B, which shows the trend of time duration dependency. With the increasing of TSA dose and time duration, expression of HDAC2 in cancer cells attenuated, but that of p53 increased. Conclusion TSA had the HDAC inhibitor's character, which could inhibit the expression of HDAC2 and promote activation and expression of p53, inhibit proliferation of HEC-1B at the same time.
出处 《华中医学杂志》 CAS 2009年第1期24-27,共4页 Central China Medical Journal
关键词 曲古菌素A 去乙酰化酶2 P53蛋白 HEC-1B细胞 Trichostatin A Histone deacetylase 2 p53 Human endometrial eancer-1B
  • 相关文献

参考文献11

二级参考文献84

  • 1JingYuanFANG YingXuanCHEN JuanLU RongLU LiYANG HongYinZHU WeiQiGU LunGenLU.Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116[J].Cell Research,2004,14(3):217-226. 被引量:46
  • 2黄江波,罗志刚,邹飞燕.CD3AK细胞联合BCG对膀胱癌细胞的体外杀伤活性研究(英文)[J].中国现代医学杂志,2004,14(12):53-55. 被引量:3
  • 3柴希运,陈惠黎.两种分化诱导剂对人肝癌细胞株丝氨酸蛋白激酶的影响[J].上海医科大学学报,1994,21(3):170-175. 被引量:5
  • 4陈瑞铭 朱德厚.人体肝癌体外细胞系BEL-7402的建立及其特征[J].实验生物学报,1978,11(1):37-47.
  • 5Ura K, Kurumizaka H, Dimitrov S, et al. Histone acetylation: influence on transcription, nucleosome mobility and positioning, and linker histone-dependent transcriptional repression [ J ]. EMBO J,1997, 16: 2096-2107.
  • 6Berger SL. An embarrassment of niches : the many covalent modifications of histones in transcriptional regulation [ J]. Oncogene,2001,20: 3007-3013.
  • 7Vigushin DM, Ali S, Pace PE, et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in Vivo[J]. Clin Cancer Res, 2001,7: 971-976.
  • 8Juan LJ, Shia WJ, Chen MH, et al. Histone deacetylases specifically down-regulate p53-dependent gene activation [ J ]. J Biol Chem, 2000, 275(7): 20436-20443.
  • 9Minucci S,Nervi C, Coco FL, et al. Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias[J]. Oncogene, 2001,20:3110-3115.
  • 10Crazzolara R, Johrer K, Johnstone RW, et al. Histone deacetylase inhibitors potently repress CXCR4 chemokine receptor expression and function in acute lymphobla.stic leukaemia[ J ]. Br J Haematol,2002, 119(4) :965-969.

共引文献46

同被引文献36

  • 1Matthias Ocker.Deacetylase inhibitors-focus on non-histone targets and effects[J].World Journal of Biological Chemistry,2010,1(5):55-61. 被引量:11
  • 2荣风年,刘薇,汤春生.丁酸钠对子宫内膜癌抑制作用的裸鼠体内实验研究[J].肿瘤防治杂志,2005,12(4):261-263. 被引量:7
  • 3Takai N,Narahara H. Preclinical studies of chemotherapy using histone deacetylaseinhibitors inendometrial cancer[J].Obstet Gynecol Int,2010.824.
  • 4Hayashi A,Horiuchi A,Kikuchi N. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma:HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin[J].International Journal of Cancer,2010,(06):1332-1346.
  • 5Krusche CA,Vloet AJ,Classen-Linke I. Class I histone deacetylase expression in the human cyclic endometrium and endometrial adenocarcinomas[J].Human Reproduction,2007,(11):2956-2966.
  • 6Fakhry H,Miyamoto T,Kashima H. Immunohistochemical detection of histone deacetylases in endometrial carcinoma:involvement of histone deacetylase 2 in theproliferation of endometrial carcinoma cells[J].Human Pathology,2010,(06):848-858.
  • 7Senese S,Zaragoza K,Minardi S. Role for histone deacetylase 1 in human tumor cell proliferation[J].Molecular and Cellular Biology,2007,(13):4784-4795.
  • 8Hoshino I,Matsubara H. Recent advances in histone deacetylase targeted cancer therapy[J].Surgery Today(Japanese Journal of Surgery ),2010,(09):809-815.
  • 9Yoshida M,Kijima M,Akita M. Potnt and specific inhabition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A[J].Journal of Biological Chemistry,1990,(28):17174-17179.
  • 10Xiong Y,Dowdy SC,Podratz KC. Histone deacetylase inhibitor decrease DNA methyltransferase-3B messenger RNA stability and down-regulate novoDNAmethyltransferase activity in human endometrial cells[J].Cancer Research,2005,(07):2684-2689.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部